









Markets
/
Stocks
/
nasdaq-oprx
/

OptimizeRx Corp

OPRX

18.920USD

+1.140+6.41%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

351.08MMarket Cap

LossP/E TTM



OptimizeRx Corp

18.920

+1.140+6.41%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-18

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

78 / 470

Overall Ranking

141 / 4721

Industry

Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 7 analysts

Buy

Current Rating

19.000

Target Price

+6.86%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 47.52% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 92.13M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 75.81.

Undervalued

The company’s latest PE is -35.26, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 14.95M shares, decreasing 32.91% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 920.88K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.89.

Financial Health

Currency: USD Updated：2025-09-18

The company's current financial score is 8.29, which is higher than the Software & IT Services industry's average of 7.27. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 29.20M, representing a year-over-year increase of 55.19%, while its net profit experienced a year-over-year increase of 138.22%.

Score

Industry at a Glance

Previous score

8.29

Change



Financials

8.09

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.76

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.13

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.19

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.28

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-18

The company’s current valuation score is 1.20, which is lower than the Software & IT Services industry's average of 2.10. Its current P/E ratio is -33.14, which is -70.18% below the recent high of -9.88 and 46.50% above the recent low of -17.73.

Score

Industry at a Glance

Previous score

1.20

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 78/470

No Data

Earnings Forecast

Currency: USD Updated：2025-09-18

The company’s current earnings forecast score is 8.29, which is higher than the Software & IT Services industry's average of 7.60. The average price target for OptimizeRx Corp is 19.00, with a high of 27.00 and a low of 11.00.

Score

Industry at a Glance

Previous score

8.29

Change

Support & Resistance

No Data

Analyst Rating

Based on 7 analysts

Buy

Current Rating

19.000

Target Price

+6.86%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

112

Total

Median

Average

Company name

Ratings

Analysts

OptimizeRx Corp

OPRX

Meta Platforms Inc

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-18

The company’s current price momentum score is 8.81, which is higher than the Software & IT Services industry's average of 7.42. Sideways: Currently, the stock price is trading between the resistance level at 19.65 and the support level at 15.50, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.81

Change

0.46

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.192

Neutral

RSI(14)

60.168

Neutral

STOCH(KDJ)(9,3,3)

66.654

Buy

ATR(14)

1.085

High Vlolatility

CCI(14)

114.614

Buy

Williams %R

12.941

Overbought

TRIX(12,20)

0.623

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

17.896

Buy

MA10

18.077

Buy

MA20

17.795

Buy

MA50

15.640

Buy

MA100

13.933

Buy

MA200

10.101

Buy

Institutional Confidence

Currency: USD Updated：2025-09-18

The company’s current institutional recognition score is 7.00, which is higher than the Software & IT Services industry's average of 6.81. The latest institutional shareholding proportion is 80.84%, representing a quarter-over-quarter decrease of 2.79%. The largest institutional shareholder is The Vanguard, holding a total of 920.88K shares, representing 4.96% of shares outstanding, with 2.16% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Whetstone Capital Advisors, LLC

1.51M

Weintraub (Michael)

1.38M

BlackRock Institutional Trust Company, N.A.

1.17M

+0.47%

The Vanguard Group, Inc.

Star Investors

921.85K

-1.47%

Royce Investment Partners

Star Investors

994.30K

-7.04%

William Blair & Company, L.L.C. (Research)

631.03K

+4.93%

Rice Hall James & Associates, LLC

576.17K

-0.27%

Febbo (William J)

530.85K

-13.54%

Parkman Healthcare Partners LLC

475.00K

Kennedy Capital Management LLC

478.40K

-19.46%

Risk Assessment

Currency: USD Updated：2025-09-18

The company’s current risk assessment score is 3.24, which is lower than the Software & IT Services industry's average of 4.01. The company's beta value is 1.23. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.